Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
2021 · Journal of Asthma and Allergy · 60 citations
https://doi.org/10.2147/jaa.s318892
M
Meagan P. O’Brien
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
2.8K
Citations
24
h-index
33
i10-index
Meagan P. O’Brien is an academic researcher from Regeneron (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & HIV Research and Treatment & COVID-19 Clinical Research Studies. The author has an h-index of 24, co-authored 64 publications.
Papers by this author
worksPlatelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity
2018 · JACC Basic to Translational Science · 43 citations
https://doi.org/10.1016/j.jacbts.2017.10.005
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
2025 · The Lancet · 2 citations
https://doi.org/10.1016/s0140-6736(25)02097-5
P10-05. Suppression of human dendritic cell function during acute HIV infection
2009 · Retrovirology · 0 citations
https://doi.org/10.1186/1742-4690-6-s3-p136
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat